Nephrocare Health IPO
Nephrocare Health IPO
Nephrocare Health Services Ltd., founded in 2010, is India’s and Asia’s largest dialysis chain, providing complete dialysis care, including haemodialysis, home/mobile dialysis, and wellness programs. The company operates 519 clinics globally (51 internationally) and approximately 78% of its Indian clinics are located in Tier II and III cities. Nephrocare follows an asset-light model, partnering with major hospital chains like Max, Fortis, and Care Hospitals. The company has a track record of growth, profitability, and positive returns since recovering from losses in FY23.
Investment Timeline
🤖 Smart Analysis
*AI score is algorithmic and for educational purposes only.
🎯 Application Strategy
Action: ⚠️ NEUTRAL - Mixed signals, proceed with caution
Lots: Single lot only for diversification
⏳ Timing Advice
👍 Flexible timing - Apply by Day 3, good allotment chances
Key Factor Analysis
Issue Details
Object of the Issue
The company proposes to utilize the Net Proceeds from the Issue towards the following objects:
- Capital expenditure by the Company for opening new dialysis clinics in India (₹129.11 Cr).
- Pre-payment, or scheduled repayment, in full or part, of certain borrowings availed by the Company (₹136.00 Cr).
- General corporate purposes.
Frequently Asked Questions
What is the current GMP of Nephrocare Health IPO?
What is the AI Prediction for Nephrocare Health IPO?
When will the allotment for Nephrocare Health IPO be announced?
What is the listing date for Nephrocare Health IPO?
Liability Disclaimer: Ipofly.com is an informational platform. We are not SEBI registered. The information provided here (including GMP and AI analysis) is for educational purposes only and should not be considered financial advice. Investments in the stock market are subject to market risks. Please consult your financial advisor before investing.